シングルユースバイオリアクター市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、細胞タイプ別、分子タイプ別、用途別、最終用途別、地域別、市場競合、2020-2030年

シングルユースバイオリアクター（サブテーマ）の世界市場は、2024年に23億米ドルと評価され、予測期間中にCAGR 12.85％で成長し、2030年には47億5,000万米ドルに達すると予測されています。

市場の成長を牽引しているのは、研究開発活動の活発化、共同研究の拡大、新規ワクチンや治療薬に対する需要の高まりです。慢性疾患や感染症の増加に加え、モノクローナル抗体の市場開拓が進んでいることも、市場の拡大をさらに後押ししています。SUBは、従来のステンレス製システムに代わる拡張性とコスト効率に優れたシステムであり、臨床用と商業用の両方の製造において魅力的なものとなっています。

例えば、2022年1月、HaemaLogiX LtdはLonzaと提携し、κ骨髄腫抗原を標的とするモノクローナル抗体KappaMabの臨床バッチを製造しました。さらに、生物学的製剤の急速な普及、生物学的製剤研究に対する政府の資金援助、個別化医療への関心の高まりは、世界の製薬・バイオ医薬品セクター全体でSUBの需要を促進しています。汚染リスクの低減、ターンアラウンドタイムの短縮、最小限の洗浄要件などの利点により、SUBは最新のバイオプロセス業務においてますます不可欠なものとなっています。

市場促進要因

バイオ医薬品需要とバイオシミラー生産の急増

主な市場動向

バイオプロセスにおけるデジタル技術の統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のシングルユースバイオリアクター市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（使い捨てバイオリアクターシステム、使い捨てメディアバッグ、使い捨てろ過アセンブリ、その他の製品）
  • タイプ別（撹拌槽型SUB、波動誘起型SUB、気泡塔型SUB、その他SUB）
  • 細胞の種類別（哺乳類細胞、細菌細胞、酵母細胞、その他の細胞）
  • 分子別（モノクローナル抗体、ワクチン、遺伝子組み換え細胞、幹細胞、その他の分子）
  • 用途別（研究開発、バイオプロダクション）
  • 用途別（ラボスケール生産、パイロットスケール生産、大規模生産）
  • エンドユーザー別（製薬会社、バイオ医薬品会社、CROSおよびCMOS、学術調査機関）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024）
• 市場マップ
• 製品別
• タイプ別
• 細胞の種類別
• 分子別
• 用途別
• 用途別
• エンドユーザー別
• 地域別

第6章 北米のシングルユースバイオリアクター市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のシングルユースバイオリアクター市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のシングルユースバイオリアクター市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のシングルユースバイオリアクター市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのシングルユースバイオリアクター市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• ラボ自動化活動の需要の増加
• バイオバンクによるラボインフォマティクスの導入拡大
• 技術的に高度なソフトウェアサービスの導入の増加
• 課題
• 研究室情報科学の統合標準の欠如
• 厳しい規制

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界のシングルユースバイオリアクター市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• ABEC, INC.
• Able Corporation & Biott Corporation.
• BBI-Biotech Gmbh.
• Cellexus Biosystems PLC.
• Celltainer Biotech BV.
• Danaher Corporation
• Distek Inc.
• Eppendorf AG.
• G&G Technologies, Inc.
• Getinge AB

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Single-Use Bioreactors (SUBs) Market was valued at USD 2.30 billion in 2024 and is projected to reach USD 4.75 billion by 2030, growing at a CAGR of 12.85% during the forecast period. The market's growth is driven by increasing research and development activities, expanding collaborations, and heightened demand for novel vaccines and therapeutics. The rise in chronic and infectious diseases, along with the growing development of monoclonal antibodies, further supports market expansion. SUBs offer a scalable and cost-efficient alternative to traditional stainless-steel systems, making them attractive for both clinical and commercial manufacturing.

For instance, in January 2022, HaemaLogiX Ltd partnered with Lonza to manufacture a clinical batch of KappaMab, a monoclonal antibody targeting kappa myeloma antigen-demonstrating the role of SUBs in advanced drug development. Additionally, the rapid adoption of biologics, government funding for biologics research, and increased focus on personalized medicine are fostering demand for SUBs across global pharmaceutical and biopharmaceutical sectors. Their benefits, including reduced contamination risk, shorter turnaround times, and minimal cleaning requirements, make them increasingly indispensable in modern bioprocessing operations.

Key Market Drivers

Surge in Biopharmaceutical Demand and Biosimilar Production

The growing demand for biopharmaceutical products-particularly monoclonal antibodies, vaccines, and biosimilars-is a major driver of the single-use bioreactors market. These biologics are increasingly used to treat chronic diseases such as cancer, diabetes, and autoimmune disorders due to their targeted therapeutic effects and lower side effect profiles. SUBs offer a flexible and efficient production solution, reducing the need for time-consuming cleaning and sterilization compared to stainless-steel systems.

Supportive regulatory environments and rising public investment in biologics research are accelerating this shift. For instance, as of March 2024, the U.S. National Institutes of Health allocated USD 47.6 billion in funding, emphasizing biologics and biosimilar development. Similarly, the European Medicines Agency approved a notable number of monoclonal antibodies in 2023. These advancements, alongside favorable government policies, are promoting the adoption of SUBs to meet the evolving demands of large-scale and cost-effective biomanufacturing.

Key Market Trends

Integration of Digital Technologies in Bioprocessing

The integration of digital tools such as IoT, AI, and machine learning into SUB platforms is revolutionizing biomanufacturing practices. These technologies enable real-time monitoring, predictive analytics, and advanced process control-enhancing efficiency, product quality, and compliance.

Referred to as Bioprocessing 4.0, this evolution is being actively supported by regulatory agencies. For example, the U.S. FDA is encouraging the adoption of advanced manufacturing technologies to boost production resilience and safety. As a result, biopharmaceutical firms are increasingly investing in digitalized SUB systems, enabling smarter, faster, and more agile production processes. This synergy between single-use bioreactor platforms and digital transformation is expected to drive sustained improvements in scalability, traceability, and operational performance in the bioprocessing sector.

Key Market Players

• ABEC, INC.
• Able Corporation & Biott Corporation
• BBI-Biotech GmbH
• Cellexus Biosystems PLC
• Celltainer Biotech BV
• Danaher Corporation
• Distek Inc.
• Eppendorf AG
• G&G Technologies, Inc.
• Getinge AB

Report Scope:

In this report, the Global Single-Use Bioreactors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Single-Use Bioreactors Market, By Product:

• Single use bioreactor systems
• Single use media bags
• Single use filtration assemblies
• Other products

Single-Use Bioreactors Market, By Type:

• Stirred tank SUB
• Wave induced SUB
• Bubble Column SUB
• Other SUB

Single-Use Bioreactors Market, By Type of Cell:

• Mammalian Cell
• Bacterial Cell
• Yeast Cell
• Other Cells

Single-Use Bioreactors Market, By Molecule:

• Monoclonal Antibodies
• Vaccines
• Gene Modified Cells
• Stem Cells
• Other molecules

Single-Use Bioreactors Market, By Application:

• Research and Development
• Bioproduction

Single-Use Bioreactors Market, By Usage:

• Lab scale production
• Pilot scale production
• Large scale production

Single-Use Bioreactors Market, By End User:

• Pharmaceutical and Biopharmaceutical companies
• CROSs & CMOS
• Academic and Research Institutes

Single-Use Bioreactors Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Single-Use Bioreactors Market.

Available Customizations:

Global Single-Use Bioreactors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Single-Use Bioreactors Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
  • 5.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
  • 5.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
  • 5.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
  • 5.2.5. By Application (Research and Development, Bioproduction)
  • 5.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
  • 5.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
  • 5.2.8. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.9. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Product
• 5.3.2 By Type
• 5.3.3 By Type of Cell
• 5.3.4 By Molecule
• 5.3.5 By Application
• 5.3.6 By Usage
• 5.3.7 By End User
• 5.3.5 By Region

6. North America Single-Use Bioreactors Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
  • 6.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
  • 6.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
  • 6.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
  • 6.2.5. By Application (Research and Development, Bioproduction)
  • 6.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
  • 6.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
  • 6.2.8. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Single-Use Bioreactors Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Type of Cell
      • 6.3.1.2.4. By Molecule
      • 6.3.1.2.5. By Application
      • 6.3.1.2.6. By Usage
      • 6.3.1.2.7. By End User
  • 6.3.2. Canada Single-Use Bioreactors Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Type of Cell
      • 6.3.2.2.4. By Molecule
      • 6.3.2.2.5. By Application
      • 6.3.2.2.6. By Usage
      • 6.3.2.2.7. By End User
  • 6.3.3. Mexico Single-Use Bioreactors Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Type of Cell
      • 6.3.3.2.4. By Molecule
      • 6.3.3.2.5. By Application
      • 6.3.3.2.6. By Usage
      • 6.3.3.2.7. By End User

7. Europe Single-Use Bioreactors Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
  • 7.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
  • 7.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
  • 7.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
  • 7.2.5. By Application (Research and Development, Bioproduction)
  • 7.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
  • 7.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
  • 7.2.8. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Single-Use Bioreactors Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Type of Cell
      • 7.3.1.2.4. By Molecule
      • 7.3.1.2.5. By Application
      • 7.3.1.2.6. By Usage
      • 7.3.1.2.7. By End User
  • 7.3.2. Germany Single-Use Bioreactors Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Type of Cell
      • 7.3.2.2.4. By Molecule
      • 7.3.2.2.5. By Application
      • 7.3.2.2.6. By Usage
      • 7.3.2.2.7. By End User
  • 7.3.3. United Kingdom Single-Use Bioreactors Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Type of Cell
      • 7.3.3.2.4. By Molecule
      • 7.3.3.2.5. By Application
      • 7.3.3.2.6. By Usage
      • 7.3.3.2.7. By End User
  • 7.3.4. Italy Single-Use Bioreactors Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Type of Cell
      • 7.3.4.2.4. By Molecule
      • 7.3.4.2.5. By Application
      • 7.3.4.2.6. By Usage
      • 7.3.4.2.7. By End User
  • 7.3.5. Spain Single-Use Bioreactors Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Type of Cell
      • 7.3.5.2.4. By Molecule
      • 7.3.5.2.5. By Application
      • 7.3.5.2.6. By Usage
      • 7.3.5.2.7. By End User

8. Asia-Pacific Single-Use Bioreactors Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
  • 8.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
  • 8.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
  • 8.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
  • 8.2.5. By Application (Research and Development, Bioproduction)
  • 8.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
  • 8.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
  • 8.2.8. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Single-Use Bioreactors Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Type of Cell
      • 8.3.1.2.4. By Molecule
      • 8.3.1.2.5. By Application
      • 8.3.1.2.6. By Usage
      • 8.3.1.2.7. By End User
  • 8.3.2. India Single-Use Bioreactors Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Type of Cell
      • 8.3.2.2.4. By Molecule
      • 8.3.2.2.5. By Application
      • 8.3.2.2.6. By Usage
      • 8.3.2.2.7. By End User
  • 8.3.3. Japan Single-Use Bioreactors Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Type of Cell
      • 8.3.3.2.4. By Molecule
      • 8.3.3.2.5. By Application
      • 8.3.3.2.6. By Usage
      • 8.3.3.2.7. By End User
  • 8.3.4. South Korea Single-Use Bioreactors Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Type of Cell
      • 8.3.4.2.4. By Molecule
      • 8.3.4.2.5. By Application
      • 8.3.4.2.6. By Usage
      • 8.3.4.2.7. By End User
  • 8.3.5. Australia Single-Use Bioreactors Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Type of Cell
      • 8.3.5.2.4. By Molecule
      • 8.3.5.2.5. By Application
      • 8.3.5.2.6. By Usage
      • 8.3.5.2.7. By End User

9. South America Single-Use Bioreactors Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
  • 9.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
  • 9.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
  • 9.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
  • 9.2.5. By Application (Research and Development, Bioproduction)
  • 9.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
  • 9.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
  • 9.2.8. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Single-Use Bioreactors Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Type of Cell
      • 9.3.1.2.4. By Molecule
      • 9.3.1.2.5. By Application
      • 9.3.1.2.6. By Usage
      • 9.3.1.2.7. By End User
  • 9.3.2. Argentina Single-Use Bioreactors Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Type of Cell
      • 9.3.2.2.4. By Molecule
      • 9.3.2.2.5. By Application
      • 9.3.2.2.6. By Usage
      • 9.3.2.2.7. By End User
  • 9.3.3. Colombia Single-Use Bioreactors Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Type of Cell
      • 9.3.3.2.4. By Molecule
      • 9.3.3.2.5. By Application
      • 9.3.3.2.6. By Usage
      • 9.3.3.2.7. By End User

10. Middle East and Africa Single-Use Bioreactors Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
  • 10.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
  • 10.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
  • 10.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
  • 10.2.5. By Application (Research and Development, Bioproduction)
  • 10.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
  • 10.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
  • 10.2.8. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Single-Use Bioreactors Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Type of Cell
      • 10.3.1.2.4. By Molecule
      • 10.3.1.2.5. By Application
      • 10.3.1.2.6. By Usage
      • 10.3.1.2.7. By End User
  • 10.3.2. Saudi Arabia Single-Use Bioreactors Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Type of Cell
      • 10.3.2.2.4. By Molecule
      • 10.3.2.2.5. By Application
      • 10.3.2.2.6. By Usage
      • 10.3.2.2.7. By End User
  • 10.3.3. UAE Single-Use Bioreactors Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Type of Cell
      • 10.3.3.2.4. By Molecule
      • 10.3.3.2.5. By Application
      • 10.3.3.2.6. By Usage
      • 10.3.3.2.7. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.1.1 Growing demand for lab automation activities
• 11.1.2 Growing adoption of lab informatics by biobanks
• 11.1.3 Growing introduction of technologically advanced software services
• 11.2. Challenges
• 11.2.1 Lack of integration standards for laboratory informatics
• 11.2.2 Stringent Regulations

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Single-Use Bioreactors Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. ABEC, INC.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Able Corporation & Biott Corporation.
• 15.3. BBI-Biotech Gmbh.
• 15.4. Cellexus Biosystems PLC.
• 15.5. Celltainer Biotech BV.
• 15.6. Danaher Corporation
• 15.7. Distek Inc.
• 15.8. Eppendorf AG.
• 15.9. G&G Technologies, Inc.
• 15.10. Getinge AB

16. Strategic Recommendations

17. About Us & Disclaimer